Buy & Sell Zillow Group Inc Class C (Z) – Zillow Group Inc Class C Price Today
Aura AI Summary
Key Stats
- $7.50BMarket Cap
- MediaSector
- -30.87%3M Drawdown
- $7.14BEnterprise Value
- -Dividend Yield
- 28 daysTypical Hold Time
Zillow Group Inc Class C (Z) is currently valued at a market capitalization of $7.50B, with an enterprise value of $7.14B. Over the past 52 weeks, Zillow Group Inc Class C has traded between a low of $32.31 and a high of $90.35, highlighting its annual price range. Over the past three months, Zillow Group Inc Class C has recorded a drawdown of -30.87%, reflecting recent price volatility. On average, investors hold Zillow Group Inc Class C for approximately 28 days, indicating typical investor behavior on the platform.
About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Most Recent News
Fire engulfs Medline warehouse, causing inventory loss and short-term margin impact.
A fire destroyed Medline's 1 million-square-foot medical equipment warehouse in Tracy, California, affecting about 4% of its U.S. warehouse space. The blaze caused inventory losses and disrupted operations, creating short-term margin pressure as the ...

SpaceX prioritizes growth over profits, following Amazon's strategy to build future value.
SpaceX is choosing to focus on long-term growth rather than immediate profitability, similar to Amazon's approach in its early years. Experts say SpaceX could be profitable now if it reduced spending on projects like Starship and AI infrastructure, b...

New data show Lyell's ronde-cel CAR T-cell therapy is safe and effective for large B-cell lymphoma.
Lyell Immunopharma presented updated safety and translational data for its CAR T-cell therapy, ronde-cel, in treating relapsed or refractory large B-cell lymphoma (LBCL). Over 100 patients treated showed no severe cytokine release syndrome (CRS) and ...
